Author: Andrew Bland, MD, MBA, MS
Introduction
Metabolic acidosis is a common complication in critically ill patients that carries significant morbidity and mortality. The management of this condition remains controversial, particularly regarding the use of intravenous sodium bicarbonate as a therapeutic intervention.
This review examines recent medical literature from 2020 onwards to evaluate three critical aspects:
- The clinical effectiveness of IV sodium bicarbonate in improving patient outcomes
- The risks associated with bicarbonate therapy, with particular attention to paradoxical intracellular acidosis
- The relationship between blood pH and vasopressor effectiveness, especially at pH levels below 7.20
Effectiveness of IV Sodium Bicarbonate Therapy
Sodium bicarbonate administration in critically ill patients may facilitate rapid normalization of arterial blood gas parameters. However, the evidence for clinical outcome benefits remains limited.
Biochemical Effects
A scoping review and systematic review assessing the biochemical and physiological effects of IV sodium bicarbonate in critically ill patients with metabolic acidosis found that it:
| Parameter | Effect |
|---|
| Blood pH | Increased |
| Base excess | Increased |
| Serum bicarbonate | Increased |
| Serum sodium | Increased |
| PaCO2 | Increased |
| Anion gap | Decreased |
| Potassium | Decreased |
Only one study reported mortality effects, with a relative risk of 0.83 (low certainty evidence).
Benefit in AKI
Clinical Pearl: Treatment of acute metabolic acidosis with sodium bicarbonate in patients with sepsis had no impact on overall mortality but appeared beneficial for those with coexistent acute kidney injury (AKI). Both a delay in the need for renal replacement therapy and a reduction in the need for RRT was observed in these patients.
Risks of Sodium Bicarbonate Therapy
Paradoxical Intracellular Acidosis
One of the primary concerns with bicarbonate therapy is paradoxical intracellular acidosis. The mechanism occurs because sodium bicarbonate reacts with hydrogen ions to form carbonic acid, which dissociates into water and carbon dioxide. While bicarbonate ions diffuse slowly across cell membranes, CO2 diffuses rapidly, potentially leading to a transient intracellular acidosis as CO2 combines with water to form carbonic acid intracellularly.
Key Finding: Paradoxical acidosis has been demonstrated experimentally but in conditions so far removed from human physiology as to make the results inapplicable to clinical medicine. When in vitro experiments are repeated under conditions designed to simulate clinical practice, progressive intracellular alkalinization rather than acidosis is observed. In bicarbonate buffering systems, hepatocytes underwent a marked increase in intracellular pH without any initial decrease — suggesting that in vivo buffering conditions may protect against paradoxical intracellular acidosis.
Additional Risks
Complications to Monitor:
- Increased PaCO2 — especially problematic in patients with limited pulmonary reserve who cannot eliminate the increased CO2 load
- Hyperosmolality and hypernatremia
- Volume overload
- pH overcorrection resulting in metabolic alkalosis
- Hypocalcemia
- Decreased tissue oxygenation
- Hypokalemia
Cerebral Effects
Sodium bicarbonate administration can affect the brain through multiple mechanisms. It may induce cerebral edema by increasing cerebral blood flow, as paradoxical CSF acidosis after bicarbonate administration could induce arterial vasodilatation. Studies have found that sodium bicarbonate caused a significant increase in mean cerebral blood flow in all areas of the brain and was associated with decreased intracellular pH in the whole body.
Effect of Blood pH on Vasopressor Effectiveness
Emerging evidence supports the concept that severe acidosis (pH < 7.20) reduces the effectiveness of vasopressors used in critical care.
Effects on Vasopressin
A retrospective, multicenter, observational cohort study found that compared with higher arterial pH, patients with septic shock and low arterial pH had lower odds of vasopressin response and higher catecholamine doses after vasopressin initiation.
Quantified Relationship:
For each 0.1 unit arterial pH below 7.40:
• Vasopressin response OR: 0.79 (95% CI 0.72–0.87)
• Norepinephrine-equivalent dose increase at 1 hr: +1.5 μg/min (95% CI 0.5–2.5)
• Norepinephrine-equivalent dose increase at 6 hr: +2.5 μg/min (95% CI 1.4–3.5)
At pH 7.20 (0.2 units below 7.40):
• ~40% lower odds of responding to vasopressin
• Significantly higher catecholamine doses required
Effects on Catecholamines
More than half of patients with septic shock have a concomitant decrease in blood pH levels and resulting acidemia. Experimental evidence suggests that in tightly controlled conditions, acidosis decreases the response of adrenergic receptors to agonists through several mechanisms:
- Direct effects on adrenergic receptor function
- Altered calcium handling in vascular smooth muscle
- Impaired signal transduction pathways
- Decreased cardiac contractility
Clinical Pearl: Sodium bicarbonate could be associated with higher responsiveness to vasopressors in acidotic patients who are dependent on vasopressors. However, in one study there was no statistical difference in ICU mortality, possibly because patients who received early sodium bicarbonate were sicker and had lower pH and higher lactate levels at the time of metabolic acidosis diagnosis.
Conclusion and Clinical Implications
The use of IV sodium bicarbonate in critically ill patients remains a complex therapeutic decision.
Clinical Recommendations:
- AKI patients: Bicarbonate therapy may be beneficial in patients with AKI and metabolic acidosis, potentially reducing the need for renal replacement therapy
- Severe acidosis + vasopressors: In patients with pH < 7.20 who require high-dose vasopressors, bicarbonate therapy may improve vasopressor responsiveness, though this benefit must be weighed against potential risks
- Ventilatory monitoring: Careful attention to ventilatory status to ensure adequate CO2 elimination, as well as to electrolyte balance (particularly sodium and potassium)
- Individualized approach: The decision to administer bicarbonate should be individualized based on the patient's clinical condition, the cause of acidosis, and the presence of organ dysfunction
© 2025 Andrew Bland, MD, MBA, MS — Urine Nephrology Now